DEATH
Clinical trials for DEATH explained in plain language.
Never miss a new study
Get alerted when new DEATH trials appear
Sign up with your email to follow new studies for DEATH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Vitamin d levels linked to heart attack recovery in new study
Disease control CompletedThis study looked at whether getting vitamin D levels to a healthy range (above 40 ng/mL) after a heart attack could lower the chance of having another heart attack, stroke, heart failure, or dying. About 634 adults who had a recent heart attack took part. Half received standard …
Matched conditions: DEATH
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
DNA-Guided heart drug choice may save lives in coronary artery disease
Disease control CompletedThis study looked at whether using a person's genetic information to choose their blood-thinning medication (clopidogrel or an alternative) leads to better outcomes after a heart procedure. 283 adults with chronic coronary artery disease who had a stent placed were split into two…
Matched conditions: DEATH
Phase: NA • Sponsor: Vistamedi Ltd. • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Heart surgery in infants: new study reveals hidden Long-Term risks
Knowledge-focused CompletedThis study reviewed medical records of 901 infants who had surgery for aortic coarctation (a narrowed aorta) before age one. Researchers wanted to find out how many later developed high blood pressure or re-narrowing of the aorta. The goal is to better understand these risks and …
Matched conditions: DEATH
Sponsor: Institut Saint Pierre • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC
-
Which sedation is safer for TAVR? propofol vs dexmedetomidine
Knowledge-focused CompletedThis study compared two common sedation drugs, propofol and dexmedetomidine, in 65 older adults undergoing a less invasive heart valve replacement called TAVR. The goal was to see which drug leads to better kidney function, less confusion, and fewer complications after the proced…
Matched conditions: DEATH
Phase: NA • Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:01 UTC